Related by context. Frequent words. (Click for all words.) 63 prospective randomized controlled 62 TRITON TIMI 62 TIMI 62 CYPHER R Stent 62 CYPHER ® Stent 61 placebo controlled clinical 60 Drug Eluting Stents 60 Stenting 60 randomized controlled clinical 60 echocardiographic 59 subgroup analyzes 59 composite endpoint 59 substudy 59 Phase III randomized 59 carotid stenting 59 multicentre 59 stable angina 58 multicenter randomized 58 Acute Coronary Syndrome 58 carotid artery stenting 58 Coronary Stent 58 Myocardial Infarction 57 TAXUS stent 57 SPIRIT III 57 RESOLUTE 57 randomized Phase III 57 prospective randomized 57 noninferiority 56 Solid Tumors 56 placebo controlled randomized 56 neoadjuvant 56 retrospective cohort study 56 RTOG 56 ADAS cog 56 endovascular repair 56 PCa 56 histologic 55 virologic response 55 STEMI patients 55 vertebral fracture 55 multicenter 55 coronary revascularization 55 active comparator 55 thromboembolic events 55 carotid endarterectomy 55 multicenter clinical 55 ERCP 55 DAS# [002] 55 preoperatively 55 stent restenosis 55 virologic 55 ACUITY 55 Cardiovascular Risk 55 sustained virologic response 54 myocardial perfusion imaging 54 ST elevation myocardial 54 acute myocardial infarction AMI 54 coronary calcium 54 nomogram 54 secondary efficacy endpoints 54 Diabetic Retinopathy 54 COPAXONE R 54 placebo controlled studies 54 PFO closure 54 randomized clinical trials 54 CT angiography 54 CABG 54 EORTC 54 T2DM 54 FDG PET 54 myocardial infarctions 54 Pharmacokinetic 54 blind randomized controlled 54 double blinded placebo 54 randomized clinical 54 secondary endpoint 54 cardiac dysfunction 54 carotid intima media 54 prospective observational 54 CABG surgery 54 endarterectomy 53 acute coronary syndromes 53 thromboembolism 53 risk stratification 53 microalbuminuria 53 tocilizumab 53 multicenter study 53 NGAL 53 TAXUS 53 randomized controlled 53 RCTs 53 tipranavir 53 randomized controlled clinical trials 53 Radiographic 53 myocardial infarction MI 53 left ventricular dysfunction 53 coronary angiography 53 Phase IIa trial 53 pulmonary embolism PE 53 chemoradiotherapy 53 D dimer